Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03308396
Title Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ajjai Alva, MD
Indications

clear cell renal cell carcinoma

Therapies

Durvalumab + Guadecitabine

Guadecitabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.